CLIN LUNG CANCER 润色咨询

Clinical Lung Cancer

出版年份:1999 年文章数:1297 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:3.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1236990, encodeId=d3151236990de, content=什么是论著, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Aug 06 21:15:11 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207477, encodeId=1d14120e47779, content=请问这个杂志论著类文章,with editor后多久送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f5f6583127, createdName=ms6000001570575897, createdTime=Thu Mar 31 10:57:20 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806140, encodeId=80fe80614014, content=请问大家投稿后with editor 多久会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=781a2412076, createdName=1237ad61m74暂无昵称, createdTime=Tue Aug 04 16:29:04 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100050, encodeId=a3a71100050f9, content=什么是Protocol?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100049, encodeId=1bb61100049a4, content=什么是comment?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073990, encodeId=a5e710e3990cf, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肺癌;NSCLC;非小细胞肺癌<br>经验分享:肺癌领域的专刊,值得推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Thu Nov 25 22:08:48 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570785, encodeId=e0245e078586, content=请问大家有人投过这个杂志的个案吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3901732351, createdName=荼藤, createdTime=Sat May 11 00:00:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898909, encodeId=ff8b898909cf, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:感觉挺快的,一周多送出外审,一个月修回,两个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cd72428737, createdName=123b006cm84暂无昵称, createdTime=Fri Nov 13 11:12:48 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917132, encodeId=803d91e13232, content=请问这个杂志有投稿前咨询吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ad5420475, createdName=ms9000000350038058, createdTime=Sat Jan 16 12:20:45 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575449, encodeId=69785e54494e, content=前面审稿挺快的,但是修回后with editor状态1个多月了,发邮件也没有回复,等得好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKug7j7FSiaWwBuzAPRdcYV0M7BMiaF21VBo5wgNKkU53Fc1ib3ia2DYicAVTXwiayXqNtIFqu8ubAIWDVg/132, createdBy=4e6d1959362, createdName=Mimo2018, createdTime=Wed Aug 28 09:23:00 CST 2019, time=2019-08-28, status=1, ipAttribution=)]
    2022-08-06 ms8000000798079608

    什么是论著

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1236990, encodeId=d3151236990de, content=什么是论著, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Aug 06 21:15:11 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207477, encodeId=1d14120e47779, content=请问这个杂志论著类文章,with editor后多久送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f5f6583127, createdName=ms6000001570575897, createdTime=Thu Mar 31 10:57:20 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806140, encodeId=80fe80614014, content=请问大家投稿后with editor 多久会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=781a2412076, createdName=1237ad61m74暂无昵称, createdTime=Tue Aug 04 16:29:04 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100050, encodeId=a3a71100050f9, content=什么是Protocol?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100049, encodeId=1bb61100049a4, content=什么是comment?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073990, encodeId=a5e710e3990cf, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肺癌;NSCLC;非小细胞肺癌<br>经验分享:肺癌领域的专刊,值得推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Thu Nov 25 22:08:48 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570785, encodeId=e0245e078586, content=请问大家有人投过这个杂志的个案吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3901732351, createdName=荼藤, createdTime=Sat May 11 00:00:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898909, encodeId=ff8b898909cf, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:感觉挺快的,一周多送出外审,一个月修回,两个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cd72428737, createdName=123b006cm84暂无昵称, createdTime=Fri Nov 13 11:12:48 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917132, encodeId=803d91e13232, content=请问这个杂志有投稿前咨询吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ad5420475, createdName=ms9000000350038058, createdTime=Sat Jan 16 12:20:45 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575449, encodeId=69785e54494e, content=前面审稿挺快的,但是修回后with editor状态1个多月了,发邮件也没有回复,等得好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKug7j7FSiaWwBuzAPRdcYV0M7BMiaF21VBo5wgNKkU53Fc1ib3ia2DYicAVTXwiayXqNtIFqu8ubAIWDVg/132, createdBy=4e6d1959362, createdName=Mimo2018, createdTime=Wed Aug 28 09:23:00 CST 2019, time=2019-08-28, status=1, ipAttribution=)]
    2022-03-31 ms6000001570575897

    请问这个杂志论著类文章,with editor后多久送外审

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1236990, encodeId=d3151236990de, content=什么是论著, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Aug 06 21:15:11 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207477, encodeId=1d14120e47779, content=请问这个杂志论著类文章,with editor后多久送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f5f6583127, createdName=ms6000001570575897, createdTime=Thu Mar 31 10:57:20 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806140, encodeId=80fe80614014, content=请问大家投稿后with editor 多久会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=781a2412076, createdName=1237ad61m74暂无昵称, createdTime=Tue Aug 04 16:29:04 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100050, encodeId=a3a71100050f9, content=什么是Protocol?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100049, encodeId=1bb61100049a4, content=什么是comment?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073990, encodeId=a5e710e3990cf, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肺癌;NSCLC;非小细胞肺癌<br>经验分享:肺癌领域的专刊,值得推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Thu Nov 25 22:08:48 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570785, encodeId=e0245e078586, content=请问大家有人投过这个杂志的个案吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3901732351, createdName=荼藤, createdTime=Sat May 11 00:00:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898909, encodeId=ff8b898909cf, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:感觉挺快的,一周多送出外审,一个月修回,两个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cd72428737, createdName=123b006cm84暂无昵称, createdTime=Fri Nov 13 11:12:48 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917132, encodeId=803d91e13232, content=请问这个杂志有投稿前咨询吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ad5420475, createdName=ms9000000350038058, createdTime=Sat Jan 16 12:20:45 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575449, encodeId=69785e54494e, content=前面审稿挺快的,但是修回后with editor状态1个多月了,发邮件也没有回复,等得好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKug7j7FSiaWwBuzAPRdcYV0M7BMiaF21VBo5wgNKkU53Fc1ib3ia2DYicAVTXwiayXqNtIFqu8ubAIWDVg/132, createdBy=4e6d1959362, createdName=Mimo2018, createdTime=Wed Aug 28 09:23:00 CST 2019, time=2019-08-28, status=1, ipAttribution=)]
    2020-08-04 1237ad61m74暂无昵称

    请问大家投稿后with editor 多久会送审

    4

    展开4条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1236990, encodeId=d3151236990de, content=什么是论著, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Aug 06 21:15:11 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207477, encodeId=1d14120e47779, content=请问这个杂志论著类文章,with editor后多久送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f5f6583127, createdName=ms6000001570575897, createdTime=Thu Mar 31 10:57:20 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806140, encodeId=80fe80614014, content=请问大家投稿后with editor 多久会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=781a2412076, createdName=1237ad61m74暂无昵称, createdTime=Tue Aug 04 16:29:04 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100050, encodeId=a3a71100050f9, content=什么是Protocol?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100049, encodeId=1bb61100049a4, content=什么是comment?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073990, encodeId=a5e710e3990cf, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肺癌;NSCLC;非小细胞肺癌<br>经验分享:肺癌领域的专刊,值得推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Thu Nov 25 22:08:48 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570785, encodeId=e0245e078586, content=请问大家有人投过这个杂志的个案吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3901732351, createdName=荼藤, createdTime=Sat May 11 00:00:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898909, encodeId=ff8b898909cf, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:感觉挺快的,一周多送出外审,一个月修回,两个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cd72428737, createdName=123b006cm84暂无昵称, createdTime=Fri Nov 13 11:12:48 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917132, encodeId=803d91e13232, content=请问这个杂志有投稿前咨询吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ad5420475, createdName=ms9000000350038058, createdTime=Sat Jan 16 12:20:45 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575449, encodeId=69785e54494e, content=前面审稿挺快的,但是修回后with editor状态1个多月了,发邮件也没有回复,等得好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKug7j7FSiaWwBuzAPRdcYV0M7BMiaF21VBo5wgNKkU53Fc1ib3ia2DYicAVTXwiayXqNtIFqu8ubAIWDVg/132, createdBy=4e6d1959362, createdName=Mimo2018, createdTime=Wed Aug 28 09:23:00 CST 2019, time=2019-08-28, status=1, ipAttribution=)]
    2021-12-28 Mia

    什么是Protocol?

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1236990, encodeId=d3151236990de, content=什么是论著, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Aug 06 21:15:11 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207477, encodeId=1d14120e47779, content=请问这个杂志论著类文章,with editor后多久送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f5f6583127, createdName=ms6000001570575897, createdTime=Thu Mar 31 10:57:20 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806140, encodeId=80fe80614014, content=请问大家投稿后with editor 多久会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=781a2412076, createdName=1237ad61m74暂无昵称, createdTime=Tue Aug 04 16:29:04 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100050, encodeId=a3a71100050f9, content=什么是Protocol?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100049, encodeId=1bb61100049a4, content=什么是comment?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073990, encodeId=a5e710e3990cf, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肺癌;NSCLC;非小细胞肺癌<br>经验分享:肺癌领域的专刊,值得推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Thu Nov 25 22:08:48 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570785, encodeId=e0245e078586, content=请问大家有人投过这个杂志的个案吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3901732351, createdName=荼藤, createdTime=Sat May 11 00:00:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898909, encodeId=ff8b898909cf, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:感觉挺快的,一周多送出外审,一个月修回,两个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cd72428737, createdName=123b006cm84暂无昵称, createdTime=Fri Nov 13 11:12:48 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917132, encodeId=803d91e13232, content=请问这个杂志有投稿前咨询吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ad5420475, createdName=ms9000000350038058, createdTime=Sat Jan 16 12:20:45 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575449, encodeId=69785e54494e, content=前面审稿挺快的,但是修回后with editor状态1个多月了,发邮件也没有回复,等得好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKug7j7FSiaWwBuzAPRdcYV0M7BMiaF21VBo5wgNKkU53Fc1ib3ia2DYicAVTXwiayXqNtIFqu8ubAIWDVg/132, createdBy=4e6d1959362, createdName=Mimo2018, createdTime=Wed Aug 28 09:23:00 CST 2019, time=2019-08-28, status=1, ipAttribution=)]
    2021-12-27 桑晒麦拉

    什么是comment?

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1236990, encodeId=d3151236990de, content=什么是论著, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Aug 06 21:15:11 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207477, encodeId=1d14120e47779, content=请问这个杂志论著类文章,with editor后多久送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f5f6583127, createdName=ms6000001570575897, createdTime=Thu Mar 31 10:57:20 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806140, encodeId=80fe80614014, content=请问大家投稿后with editor 多久会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=781a2412076, createdName=1237ad61m74暂无昵称, createdTime=Tue Aug 04 16:29:04 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100050, encodeId=a3a71100050f9, content=什么是Protocol?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100049, encodeId=1bb61100049a4, content=什么是comment?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073990, encodeId=a5e710e3990cf, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肺癌;NSCLC;非小细胞肺癌<br>经验分享:肺癌领域的专刊,值得推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Thu Nov 25 22:08:48 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570785, encodeId=e0245e078586, content=请问大家有人投过这个杂志的个案吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3901732351, createdName=荼藤, createdTime=Sat May 11 00:00:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898909, encodeId=ff8b898909cf, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:感觉挺快的,一周多送出外审,一个月修回,两个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cd72428737, createdName=123b006cm84暂无昵称, createdTime=Fri Nov 13 11:12:48 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917132, encodeId=803d91e13232, content=请问这个杂志有投稿前咨询吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ad5420475, createdName=ms9000000350038058, createdTime=Sat Jan 16 12:20:45 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575449, encodeId=69785e54494e, content=前面审稿挺快的,但是修回后with editor状态1个多月了,发邮件也没有回复,等得好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKug7j7FSiaWwBuzAPRdcYV0M7BMiaF21VBo5wgNKkU53Fc1ib3ia2DYicAVTXwiayXqNtIFqu8ubAIWDVg/132, createdBy=4e6d1959362, createdName=Mimo2018, createdTime=Wed Aug 28 09:23:00 CST 2019, time=2019-08-28, status=1, ipAttribution=)]
    2021-11-25 病毒猎手

    审稿速度:2.0 | 投稿命中率:75.0
    偏重的研究方向:肺癌;NSCLC;非小细胞肺癌
    经验分享:肺癌领域的专刊,值得推荐

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1236990, encodeId=d3151236990de, content=什么是论著, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Aug 06 21:15:11 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207477, encodeId=1d14120e47779, content=请问这个杂志论著类文章,with editor后多久送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f5f6583127, createdName=ms6000001570575897, createdTime=Thu Mar 31 10:57:20 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806140, encodeId=80fe80614014, content=请问大家投稿后with editor 多久会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=781a2412076, createdName=1237ad61m74暂无昵称, createdTime=Tue Aug 04 16:29:04 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100050, encodeId=a3a71100050f9, content=什么是Protocol?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100049, encodeId=1bb61100049a4, content=什么是comment?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073990, encodeId=a5e710e3990cf, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肺癌;NSCLC;非小细胞肺癌<br>经验分享:肺癌领域的专刊,值得推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Thu Nov 25 22:08:48 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570785, encodeId=e0245e078586, content=请问大家有人投过这个杂志的个案吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3901732351, createdName=荼藤, createdTime=Sat May 11 00:00:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898909, encodeId=ff8b898909cf, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:感觉挺快的,一周多送出外审,一个月修回,两个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cd72428737, createdName=123b006cm84暂无昵称, createdTime=Fri Nov 13 11:12:48 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917132, encodeId=803d91e13232, content=请问这个杂志有投稿前咨询吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ad5420475, createdName=ms9000000350038058, createdTime=Sat Jan 16 12:20:45 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575449, encodeId=69785e54494e, content=前面审稿挺快的,但是修回后with editor状态1个多月了,发邮件也没有回复,等得好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKug7j7FSiaWwBuzAPRdcYV0M7BMiaF21VBo5wgNKkU53Fc1ib3ia2DYicAVTXwiayXqNtIFqu8ubAIWDVg/132, createdBy=4e6d1959362, createdName=Mimo2018, createdTime=Wed Aug 28 09:23:00 CST 2019, time=2019-08-28, status=1, ipAttribution=)]
    2019-05-11 荼藤

    请问大家有人投过这个杂志的个案吗?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1236990, encodeId=d3151236990de, content=什么是论著, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Aug 06 21:15:11 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207477, encodeId=1d14120e47779, content=请问这个杂志论著类文章,with editor后多久送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f5f6583127, createdName=ms6000001570575897, createdTime=Thu Mar 31 10:57:20 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806140, encodeId=80fe80614014, content=请问大家投稿后with editor 多久会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=781a2412076, createdName=1237ad61m74暂无昵称, createdTime=Tue Aug 04 16:29:04 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100050, encodeId=a3a71100050f9, content=什么是Protocol?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100049, encodeId=1bb61100049a4, content=什么是comment?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073990, encodeId=a5e710e3990cf, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肺癌;NSCLC;非小细胞肺癌<br>经验分享:肺癌领域的专刊,值得推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Thu Nov 25 22:08:48 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570785, encodeId=e0245e078586, content=请问大家有人投过这个杂志的个案吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3901732351, createdName=荼藤, createdTime=Sat May 11 00:00:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898909, encodeId=ff8b898909cf, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:感觉挺快的,一周多送出外审,一个月修回,两个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cd72428737, createdName=123b006cm84暂无昵称, createdTime=Fri Nov 13 11:12:48 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917132, encodeId=803d91e13232, content=请问这个杂志有投稿前咨询吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ad5420475, createdName=ms9000000350038058, createdTime=Sat Jan 16 12:20:45 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575449, encodeId=69785e54494e, content=前面审稿挺快的,但是修回后with editor状态1个多月了,发邮件也没有回复,等得好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKug7j7FSiaWwBuzAPRdcYV0M7BMiaF21VBo5wgNKkU53Fc1ib3ia2DYicAVTXwiayXqNtIFqu8ubAIWDVg/132, createdBy=4e6d1959362, createdName=Mimo2018, createdTime=Wed Aug 28 09:23:00 CST 2019, time=2019-08-28, status=1, ipAttribution=)]
    2020-11-13 123b006cm84暂无昵称

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享:感觉挺快的,一周多送出外审,一个月修回,两个月接收了

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1236990, encodeId=d3151236990de, content=什么是论著, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Aug 06 21:15:11 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207477, encodeId=1d14120e47779, content=请问这个杂志论著类文章,with editor后多久送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f5f6583127, createdName=ms6000001570575897, createdTime=Thu Mar 31 10:57:20 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806140, encodeId=80fe80614014, content=请问大家投稿后with editor 多久会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=781a2412076, createdName=1237ad61m74暂无昵称, createdTime=Tue Aug 04 16:29:04 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100050, encodeId=a3a71100050f9, content=什么是Protocol?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100049, encodeId=1bb61100049a4, content=什么是comment?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073990, encodeId=a5e710e3990cf, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肺癌;NSCLC;非小细胞肺癌<br>经验分享:肺癌领域的专刊,值得推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Thu Nov 25 22:08:48 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570785, encodeId=e0245e078586, content=请问大家有人投过这个杂志的个案吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3901732351, createdName=荼藤, createdTime=Sat May 11 00:00:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898909, encodeId=ff8b898909cf, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:感觉挺快的,一周多送出外审,一个月修回,两个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cd72428737, createdName=123b006cm84暂无昵称, createdTime=Fri Nov 13 11:12:48 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917132, encodeId=803d91e13232, content=请问这个杂志有投稿前咨询吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ad5420475, createdName=ms9000000350038058, createdTime=Sat Jan 16 12:20:45 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575449, encodeId=69785e54494e, content=前面审稿挺快的,但是修回后with editor状态1个多月了,发邮件也没有回复,等得好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKug7j7FSiaWwBuzAPRdcYV0M7BMiaF21VBo5wgNKkU53Fc1ib3ia2DYicAVTXwiayXqNtIFqu8ubAIWDVg/132, createdBy=4e6d1959362, createdName=Mimo2018, createdTime=Wed Aug 28 09:23:00 CST 2019, time=2019-08-28, status=1, ipAttribution=)]
    2021-01-16 ms9000000350038058

    请问这个杂志有投稿前咨询吗

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1236990, encodeId=d3151236990de, content=什么是论著, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Aug 06 21:15:11 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207477, encodeId=1d14120e47779, content=请问这个杂志论著类文章,with editor后多久送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f5f6583127, createdName=ms6000001570575897, createdTime=Thu Mar 31 10:57:20 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806140, encodeId=80fe80614014, content=请问大家投稿后with editor 多久会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=781a2412076, createdName=1237ad61m74暂无昵称, createdTime=Tue Aug 04 16:29:04 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100050, encodeId=a3a71100050f9, content=什么是Protocol?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100049, encodeId=1bb61100049a4, content=什么是comment?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073990, encodeId=a5e710e3990cf, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肺癌;NSCLC;非小细胞肺癌<br>经验分享:肺癌领域的专刊,值得推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Thu Nov 25 22:08:48 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570785, encodeId=e0245e078586, content=请问大家有人投过这个杂志的个案吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3901732351, createdName=荼藤, createdTime=Sat May 11 00:00:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898909, encodeId=ff8b898909cf, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:感觉挺快的,一周多送出外审,一个月修回,两个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cd72428737, createdName=123b006cm84暂无昵称, createdTime=Fri Nov 13 11:12:48 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917132, encodeId=803d91e13232, content=请问这个杂志有投稿前咨询吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7ad5420475, createdName=ms9000000350038058, createdTime=Sat Jan 16 12:20:45 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575449, encodeId=69785e54494e, content=前面审稿挺快的,但是修回后with editor状态1个多月了,发邮件也没有回复,等得好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKug7j7FSiaWwBuzAPRdcYV0M7BMiaF21VBo5wgNKkU53Fc1ib3ia2DYicAVTXwiayXqNtIFqu8ubAIWDVg/132, createdBy=4e6d1959362, createdName=Mimo2018, createdTime=Wed Aug 28 09:23:00 CST 2019, time=2019-08-28, status=1, ipAttribution=)]
    2019-08-28 Mimo2018

    前面审稿挺快的,但是修回后with editor状态1个多月了,发邮件也没有回复,等得好着急啊

    1

    展开1条回复
共69条页码: 2/7页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分